SH-LPS System for Safer Liver Surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a new planning system (SH-LPS) to help doctors perform safer, more precise liver surgery. It is for people whose liver tumor can be removed and who are healthy enough for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- The tumor is in your liver and can be removed with surgery.
- You are generally active and able to care for yourself (doctors call this performance status 0).
- Your liver function is good (Child-Pugh class A) and your blood tests show enough healthy cells and normal organ function.
- You have not had any tumor treatments (like chemo, radiation, or ablation) in the 28 days before the planned surgery.
- You have no serious bleeding risk, severe lung disease, or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This trial looks at a special two-step surgery called ALPPS for people with liver cancer that can't be removed in one operation. The first step helps the liver grow more healthy tissue, and then the second step removes the tumor. The goal is to understand how well this works and how the liver regenerates.
This trial tests whether a combination of three drugs given before surgery can help shrink liver cancer and improve outcomes for patients whose tumors can be removed. It is for people with intermediate-stage liver cancer that is still operable.
This trial tests whether giving chemotherapy, immunotherapy, and targeted drugs before surgery helps prevent liver cancer from coming back in patients with high-risk tumors. You would receive treatment to shrink the tumor before your scheduled surgery.
This trial tests if combining three therapies (sintilimab, lenvatinib, and HAIC) before surgery can help shrink liver tumors that are on the borderline of being removable. It's for people whose cancer has spread into nearby blood vessels but not to other organs.
This study compares two ways of doing a staged liver surgery (ALPPS) to help regrow enough liver for people with certain liver cancers. It looks at outcomes and how well the remaining liver grows after surgery, using different surgical approaches.
Hear when a new Liver Tumor; Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.